Featured Top Story
Northern Nevada Public Health is pausing the use of the current COVID-19 vaccine while it awaits federal guidance on the newer version.
From
To
Featured
Moderna is also expected to receive approval for its updated vaccine.
Featured Top Story
Moderna's COVID-19 vaccine, Spikevax, had more than $3 billion in sales last year.